Cell Reports
Volume 4, Issue 5, 12 September 2013, Pages 1049-1059
Journal home page for Cell Reports

Resource
DREADDs in Drosophila: A Pharmacogenetic Approach for Controlling Behavior, Neuronal Signaling, and Physiology in the Fly

https://doi.org/10.1016/j.celrep.2013.08.003Get rights and content
Under a Creative Commons license
open access

Highlights

  • We have adapted DREADD technology for manipulation of cellular signaling to the fly

  • DREADD technology can control behaviors and physiology in both larvae and adults

  • Behavioral control is dose dependent, rapid, and reversible

  • No specialized equipment is required; activating drug is simply fed to the fly

Summary

We have translated a powerful genetic tool, designer receptors exclusively activated by designer drugs (DREADDs), from mammalian systems to Drosophila melanogaster to selectively, rapidly, reversibly, and dose-dependently control behaviors and physiological processes in the fly. DREADDs are muscarinic acetylcholine G protein-coupled receptors evolved for loss of affinity to acetylcholine and for the ability to be fully activated by an otherwise biologically inert chemical, clozapine-N-oxide. We demonstrate its ability to control a variety of behaviors and processes in larvae and adults, including heart rate, sensory processing, diurnal behavior, learning and memory, and courtship. The advantages of this particular technology include the dose-responsive control of behaviors, the lack of a need for specialized equipment, and the capacity to remotely control signaling in essentially all neuronal and nonneuronal fly tissues.

Cited by (0)

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.